Regeneron Pharmaceuticals News
Most Popular Regeneron Pharmaceuticals Story
Regeneron eye therapy looks positive in Ph2
Regeneron (REGN) and Germany's Bayer Healthcare issued a thumb's up today on their mid-stage study of VEGF-Trap Eye. The Da Vinci study tested the therapy in patients with significant diabetic... Read more...
Latest Headlines
- February 18, 2010
- December 9, 2009
- November 11, 2009
- September 14, 2009
- July 24, 2009
- June 12, 2009
- September 3, 2008
- August 5, 2008
- May 21, 2008
- November 30, 2007
- November 29, 2007
- August 23, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
